An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse.

["Traor\u00e9, Massir\u00e9", "Gentil, Christel", "Benedetto, Chiara", "Hogrel, Jean-Yves", "De la Grange, Pierre", "Cadot, Bruno", "Benkhelifa-Ziyyat, Sofia", "Julien, Laura", "Lemaitre, M\u00e9gane", "Ferry, Arnaud", "Pi\u00e9tri-Rouxel, France", "Falcone, Sestina"]
Science translational medicine 2019
Open on PubMed

Deciphering the mechanisms that govern skeletal muscle plasticity is essential to understand its pathophysiological processes, including age-related sarcopenia. The voltage-gated calcium channel CaV1.1 has a central role in excitation-contraction coupling (ECC), raising the possibility that it may also initiate the adaptive response to changes during muscle activity. Here, we revealed the existence of a gene transcription switch of the CaV1.1 β subunit (CaVβ1) that is dependent on the innervation state of the muscle in mice. In a mouse model of sciatic denervation, we showed increased expression of an embryonic isoform of the subunit that we called CaVβ1E. CaVβ1E boosts downstream growth differentiation factor 5 (GDF5) signaling to counteract muscle loss after denervation in mice. We further reported that aged mouse muscle expressed lower quantity of CaVβ1E compared with young muscle, displaying an altered GDF5-dependent response to denervation. Conversely, CaVβ1E overexpression improved mass wasting in aging muscle in mice by increasing GDF5 expression. We also identified the human CaVβ1E analogous and show a correlation between CaVβ1E expression in human muscles and age-related muscle mass decline. These results suggest that strategies targeting CaVβ1E or GDF5 might be effective in reducing muscle mass loss in aging.